[1]Patent:WO2008/155378,2008,A1.Locationinpatent:Page/Pagecolumn73
[2]Patent:WO2007/75567,2007,A1.Locationinpatent:Page/Pagecolumn117;119-120
[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2007/75567,2007,A1Locationinpatent:Page/Pagecolumn120
[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2008/155378,2008,A1Locationinpatent:Page/Pagecolumn75
[1]CurrentPatentAssignee:SOLVIASAG;JOHNSON&JOHNSONINC-WO2016/87586,2016,A1
[1]CurrentPatentAssignee:SOLVIASAG;JOHNSON&JOHNSONINC-WO2016/87586,2016,A1Locationinpatent:Page/Pagecolumn14;15
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.
Journal: Cancer research 20101001
Title: Perera T, et al. JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models. Presented at the 99th AACR Annual Meeting; 2008 Apr 12-16
Title: De Bacco F, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst. 2011 Apr, 103(8), 645-661.
Title: Torti D, et al. A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. Int J Cancer. 2012, 130(6), 1357-1366.
